OMER — OMEROS CORP

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1285819 ·
Last close
$13.92
Market Cap
$1.01B
52W High
$21.24
52W Low
$6.70
ADV30
1,219,552
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 35,934,000 35,108,000 4,501,000 -57,356,000 248,095,000 5,070,000 338,068,000
Jun 2026 28,529,000 27,731,000 74,000 13,232,000 286,833,000 1,988,000 338,182,000
Mar 2026 9,893,000 9,306,000 -17,421,000 56,060,000 286,173,000 1,906,000 349,507,000
Dec 2025 0 — -29,081,000 86,451,000 325,632,000 9,660,000 446,863,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-68,672,000
Investing CF
$136,819,000
Financing CF
$-68,063,000
CapEx
$-65,000
Dividends Paid
—
Buybacks
$-9,878,000
EPS Diluted TTM
$1.28
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-844,403,000
Inventory
$842,000
Receivables
$46,904,000
ST Investments
$129,965,000
EBIT TTM
$15,978,000
Pretax Income TTM
$118,631,000
Interest Exp TTM
$17,148,000
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$38,422,000
EBITDA
$-71,913,000
Free Cash Flow
$183,310,496
Enterprise Value
$1,488,175,360
Total Cash
$131,953,000
Total Debt
$296,870,016
Shares Out
72,388,316
Trailing EPS
$1.65
Book Value
$-0.71
ROE
—
ROA
-18.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -122,796,000 -3,350,000 325,632,000 446,863,000 -121,231,000 -116,094,000
Dec 2024 0 -166,953,000 -156,815,000 277,079,000 459,688,000 -182,609,000 -148,803,000
Dec 2023 0 -164,530,000 -117,813,000 378,269,000 403,252,000 -24,983,000 74,726,000
Dec 2022 0 -163,389,000 47,417,000 590,969,000 505,285,000 85,684,000 -86,483,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$340,871,000
NetIncome TTM
$124,826,000
OpCashFlow TTM
—
Assets (Latest)
$286,833,000
Forward EPS
$1.15

Max Pain — expiry 2026-12-18

max pain strike: $12.00 · spot: $14.55 · call oi: 5,224 · put oi: 3,040
Expected Move to 2026-12-18: ±$2.52 (17.35%) — implied range $12.03 – $17.08 · ATM straddle on $15.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CYRX Cryoport, Inc. $999.81M $19.74 —
ANRO Alto Neuroscience, Inc. $999.16M $24.91 —
MTRI InMed Pharmaceuticals Inc. $1.02B $17.50 —
SVRA Savara Inc $988.39M $4.48 —
JBIO Jade Biosciences, Inc. $979.40M $15.40 —

News headlines (Yahoo Finance, 1h cache)

Omeros (OMER) Just Gave Investors Another Reason to Sell
2026-11-18 06:11 · Yahoo
OMER Stock Eyes Worst Day In Nearly 18 Months With European Yartemlea Setback, Paper Losses Hitting Shares
2026-11-17 17:12 · Yahoo
Omeros (OMER) Q3 2026 Earnings Call Transcript
2026-11-17 15:48 · Yahoo
Omeros Corporation Q3 2026 Earnings Call Summary
2026-11-17 13:30 · Yahoo
Omeros Corp (OMER) Q3 2026 Earnings Call Highlights: YARTEMLEA Sales Surge 30% as Operating ...
2026-11-17 05:01 · Yahoo
Omeros Q3 Earnings Call Highlights
2026-11-17 01:15 · Yahoo
Omeros falls 10% despite revenue beat
2026-11-16 21:50 · Yahoo
Omeros (OMER) Surpasses Q3 Earnings and Revenue Estimates
2026-11-16 21:15 · Yahoo
Omeros: Q3 Earnings Snapshot
2026-11-16 21:10 · Yahoo
Omeros Corporation Reports Third Quarter 2026 Financial Results
2026-11-16 21:02 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.